Highlights
- •Cardioprotective omentin-1 was higher in obese patients without metabolic syndrome
- •Non-cardioprotective visfatin and resistin were lower in metabolically healthy obese patients
- •Adipose tissue might be involved in cardiovascular risk profile of obesity
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Metabolically healthy obesity: facts and fantasies.J Clin Invest. 2019; 129: 3978-3989
- Estimation of risk for diabetes according to the metabolically healthy status stratified by degree of obesity in Korean men.Endocrine. 2015; 50: 650-658
- Metabolically healthy obesity: different prevalences using different criteria.Eur J Clin Nutr. 2010; 64: 1043-1051
- Metabolically Healthy Obese and Incident Cardiovascular Disease Events Among 3.5 Million Men and Women.J Am Coll Cardiol. 2017; 70: 1429-1437
- Fate of the metabolically healthy obese-is this term a misnomer? A study from the Clinical Practice Research Datalink.Int J Obes (Lond). 2019; 43: 1093-1101
- Adipokines and cardiovascular disease: A comprehensive review.Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017; 161: 31-40
- Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity.Circulation. 2009; 120: 1640-1645
- Circulating omentin-1 might be associated with metabolic health status in different phenotypes of body size.Arch Endocrinol Metab. 2017; 61: 567-574
- Visfatin/Nampt: an adipokine with cardiovascular impact.Mediators Inflamm. 2013; 2013946427
- Adipokines and genetic factors in overweight or obese but metabolically healthy Polish women.Neuro Endocrinol Lett. 2010; 31: 497-506
- Metabolically Healthy versus Unhealthy Morbidly Obese: Chronic Inflammation, Nitro-Oxidative Stress, and Insulin Resistance.Nutrients. 2018; : 10
- Does inflammation determine metabolic health status in obese and nonobese adults?.J Clin Endocrinol Metab. 2013; 98: E1610-E1619
Article info
Publication history
Published online: August 19, 2020
Accepted:
August 16,
2020
Received in revised form:
August 13,
2020
Received:
March 19,
2020
Identification
Copyright
© 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
